BG MEDICINE, INC. AMENDED AND RESTATED CHANGE OF CONTROL CASH SEVERANCE AGREEMENTSeverance Agreement • November 8th, 2010 • BG Medicine, Inc. • Services-medical laboratories • Massachusetts
Contract Type FiledNovember 8th, 2010 Company Industry JurisdictionTHIS Amended and Restated Change of Control Cash Severance Agreement (the “Agreement”) is dated as of August 1, 2007, 2007, by and between BG Medicine, Inc., a Delaware corporation (the “Company”), and Aram Adourian (the “Employee”).
BG MEDICINE, INC. AMENDED AND RESTATED CHANGE OF CONTROL CASH SEVERANCE AGREEMENTSeverance Agreement • November 8th, 2010 • BG Medicine, Inc. • Services-medical laboratories • Massachusetts
Contract Type FiledNovember 8th, 2010 Company Industry JurisdictionTHIS Amended and Restated Change of Control Cash Severance Agreement (the “Agreement”) is dated as of August 1, 2007, by and between BG Medicine, Inc., a Delaware corporation (the “Company”), and Anastasia Rader. (the “Employee”).
CONFIDENTIAL GALECTIN-3 LICENSE AND DISTRIBUTION AGREEMENTGalectin-3 License and Distribution Agreement • November 8th, 2010 • BG Medicine, Inc. • Services-medical laboratories • Delaware
Contract Type FiledNovember 8th, 2010 Company Industry JurisdictionThis GALECTIN-3 LICENSE AND DISTRIBUTION AGREEMENT (this “Agreement”), entered into as of May 29, 2010 (the “Effective Date”), by and between bioMérieux SA, a Société Anonyme (corporation) organized under the laws of France having its principal place of business at Chemin de l’Orme, 69280 Marcy l’Etoile, France (“BMX”). and BG Medicine, Inc., a corporation of the state of Delaware, having its principal place of business at 610 Lincoln Street North Waltham, MA 02451 (“BGM”).
CONFIDENTIAL GALECTIN-3 LICENSE AND DISTRIBUTION AGREEMENTGalectin-3 License and Distribution Agreement • November 8th, 2010 • BG Medicine, Inc. • Services-medical laboratories • Delaware
Contract Type FiledNovember 8th, 2010 Company Industry JurisdictionThis GALECTIN-3 LICENSE AND DISTRIBUTION AGREEMENT (this “Agreement”), entered into as of March 19, 2010 (the “Effective Date”), by and between Inverness Medical Innovations, Inc., a corporation of the state of Delaware, having its principal place of business at 51 Sawyer Road, Suite 200, Waltham, MA 02453 (“IMI”) and BG Medicine, Inc., a corporation of the state of Delaware, having its principal place of business at 610 Lincoln Street North Waltham, MA 02451 (“BGM”).